Bendamustine as an alternative to BCNU as conditioning regimen for autologous stem cell transplantation in patients with aggressive lymphoma: Results phase 2 study from GELTAMO

被引：0

作者：

Maria Redondo, Alba ^{[1
]}

Valcarcel, D. ^{[2
]}

Gonzalez, A. P. ^{[3
]}

Suarez-Lledo, M. ^{[4
]}

Bello, J. L. ^{[5
]}

Canales, M. ^{[6
]}

Gayoso, J. ^{[7
]}

Conde, E. ^{[8
]}

Jarque, I. ^{[9
]}

Del Campo, R. ^{[10
]}

Arranz, R. ^{[11
]}

Terol, M. J. ^{[12
]}

Rifon, J. J. ^{[13
]}

Rodriguez, M. J. ^{[14
]}

Ramirez, M. J. ^{[15
]}

Castro, N. ^{[16
]}

Sanchez, A. ^{[17
]}

Lopez-Jimenez, J. ^{[18
]}

Briones, J. ^{[19
]}

Lopez, A. ^{[20
]}

Palomera, L. ^{[21
]}

Baile, M. ^{[1
]}

Caballero, Dolores ^{[1
]}

Martin, Alejandro ^{[1
]}

机构：

[1] Hosp Univ Salamanca IBSAL, Hematol, Salamanca, Spain

[2] Hosp Valle De Hebron, Hematol, Barcelona, Spain

[3] Hosp Cent Asturias, Hematol, Oviedo, Spain

[4] Hosp Clin Barcelona, Hematol, Barcelona, Spain

[5] Complejo Hosp Univ Santiago de Compostela, Hematol, Santiago De Compostela, Spain

[6] Hosp Univ La Paz, Hematol, Madrid, Spain

[7] Hosp Gen Univ Gregorio Maranon, Hematol, Madrid, Spain

[8] Hosp Univ Marques Valdecilla, Hematol, Santander, Spain

[9] Hosp Univ Fe, Hematol, Valencia, Spain

[10] Hosp Son LLatzer, Hematol, Palma De Mallorca, Spain

[11] Hosp Princesa, Hematol, Madrid, Spain

[12] Hosp Univ Valencia, Hematol, Valencia, Spain

[13] Clin Univ Navarra, Hematol, Pamplona, Spain

[14] Hosp Univ Canarias, Hematol, San Cristobal La Laguna, Spain

[15] Hosp Jerez, Hematol, Jerez de la Frontera, Spain

[16] Hosp 12 Octubre, Hematol, Madrid, Spain

[17] Hosp Virgen de la Arreixaca, Hematol, Murcia, Spain

[18] Hosp Ramon & Cajal, Hematol, Madrid, Spain

[19] Hosp Santa Creu & Sant Pau, Hematol, Barcelona, Spain

[20] Hosp Arnau de Villanoba, Hematol, Valencia, Spain

[21] Hosp Clin Zaragoza, Hematol, Zaragoza, Spain

来源：

BONE MARROW TRANSPLANTATION | 2018年 / 53卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

P157

引用

页码：261 / 262

页数：2

共 50 条

[41] Comparison of the Low Toxicity Tecam Conditioning Regimen to BEAM in Patients with Lymphoma Requiring Autologous Stem Cell Transplantation
Rosenberg, Dana
Joffe, Erel
Rozovski, Uri
Perry, Chava
Kirgner, Ilya
Trestman, Svetlana
Gur, Odelia
Aviv, Freddy
Sarid, Nadav
Kolomansky, Albert
Gepstein, Lily
Herishanu, Yair
Naparstek, Elizabeth
BLOOD, 2015, 126 (23)
[42] Impact of Implementing a Bendamustine-Based Conditioning Regimen on Outcomes of Autologous Stem Cell Transplantation in Lymphoma while Novel Cellular Therapies Emerge
Lachance, Sylvie
Bourguignon, Alex
Boisjoly, Josie-Anne
Bouchard, Philippe
Ahmad, Imran
Bambace, Nadia
Bernard, Lea
Cohen, Sandra
Delisle, Jean-Sebastien
Fleury, Isabelle
Kiss, Thomas
Mollica, Luigina
Roy, Denis-Claude
Sauvageau, Guy
Veilleux, Olivier
Zehr, Justine
Chagnon, Miguel
Roy, Jean
TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (01): : 34.e1 - 34.e7
[43] Fotemustine, etoposide, cytarabine, and cyclophosphamide (FEAC) conditioning regimen for autologous stem cell transplantation in lymphoma
Lin, Meng
Wu, Xiaolong
Zhang, Lei
Li, Ling
Wang, Xinhua
Fu, Xiaorui
Sun, Zhenchang
Zhang, Xudong
Zhu, Linan
Yu, Hui
Chang, Yu
Nan, Feifei
Yan, Jiaqin
Zhou, Zhiyuan
Shi, Cunzhen
Zhang, Mingzhi
Li, Xin
LEUKEMIA & LYMPHOMA, 2023, 64 (03) : 605 - 612
[44] Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma
Okay, M.
Buyukasik, Y.
Demiroglu, H.
Malkan, U.
Ciftciler, R.
Aladag, E.
Aksu, S.
Haznedaroglu, I.
Sayinalp, N.
Ozcebe, O.
Goker, H.
LEUKEMIA RESEARCH, 2018, 73 : S27 - S27
[45] Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma
Okay, Mufide
Buyukasik, Yahya
Demiroglu, Haluk
Malkan, Umit Yavuz
Ciftciler, Rafiye
Aladag, Elifcan
Aksu, Salih
Haznedaroglu, Ibrahim Celalettin
Sayinalp, Nilgun
Ozcebe, Osman Ilhami
Goker, Hakan
TURKISH JOURNAL OF MEDICAL SCIENCES, 2019, 49 (04) : 985 - 992
[46] Substituting BCNU by thiotepa in the conditioning regimen of patients with lymphomas undergoing an autologous stem cell transplantation (team protocol). The experience of one centre
Maw, D.
Jansen, A.
Sims, H.
Crawley, C.
Sureda, A.
BONE MARROW TRANSPLANTATION, 2012, 47 : S449 - S449
[47] Thiotepa, Etoposide, Cyclophosphamide, ARA-C and Melphalan (TECAM) conditioning protocol for autologous stem cell transplantation - An alternative non BCNU containing regimen
Grisariu, S.
Shapira, M. Y.
Or, R.
Avni, B.
BONE MARROW TRANSPLANTATION, 2016, 51 : S441 - S441
[48] AUTOLOGOUS STEM CELL TRANSPLANTATION WITH BEEAM (BENDAMUSTINE, ETOPOSIDE, CYTARABINE, MELPHALAN) IN AGGRESSIVE NHL AND HODGKIN'S LYMPHOMA
Noesslinger, T.
Moestl, M.
Koller, E.
Tinchon, C.
Mulabecirovic, A.
Linkesch, W.
Sallaberger, E.
Hundsamer, A.
Keil, F.
BONE MARROW TRANSPLANTATION, 2014, 49 : S167 - S168
[49] Conditioning regimen with BCNU, etoposide, cytarabine and melphalan plus amifostine for outpatient autologous stem cell transplant: feasibility and outcome in 97 patients with lymphoma
Scortechini, Ilaria
Montanari, Mauro
Mancini, Giorgia
Inglese, Elena
Calandrelli, Monica
Chiarucci, Martina
Offidani, Massimo
Capelli, Debora
Gini, Guido
Poloni, Antonella
Mancini, Stefania
Raggetti, Gianmario
Leoni, Pietro
Olivieri, Attilio
LEUKEMIA & LYMPHOMA, 2014, 55 (07) : 1657 - 1660
[50] Phase 2 Study of an Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma (KMM150)
Jung, Sung-Hoon
Lee, Je-Jung
Kim, Jin Seok
Min, Chang-Ki
Kim, Kihyun
Choi, Yunsuk
Eom, Hyeon-Seok
Joo, Young Don
Kim, Sung-Hyun
Kwak, Jae-Yong
Kang, Hye Jin
Lee, Jae Hoon
Lee, Ho Sup
Mun, Yeung-Chul
Moon, Joon Ho
Sohn, Sang Kyun
Park, Seong Kyu
Park, Yong
Shin, Ho-Jin
Yoon, Sung-Soo
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (05) : 923 - 929

← 1 2 3 4 5 →